Adamyan Naira Vilenovna

Adamyan Naira Vilenovna

Biography

The naira Adamyan started the career in the pharmaceutical industry in the Janssen company (Janssen), division of pharmaceutical goods of Johnson & Johnson ("Johnson and Johnson"), in 1997 as the medical representative. Over the years, she has shown impressive results and made rapid career growth, consistently occupying the position of product manager, therapeutic group manager, and then head of department.

In 2004, Naira assumed the position of Executive Director of Pharmacoeconomics and Price Policy of Janssen, at the same time heading the hospital programs department.

In February 2006, Naira assumed the post of General Director of Janssen in Russia, and from January 1, 2010 she headed the entire region, including the CIS countries.

In May 2013, as Managing Director for Russia and CIS countries, she joined the EMEA Board of Directors.

Until October 2015, Naira Adamyan headed Johnson & Johnson in Russia, which includes all three sectors of the company.

In October 2015, Naira Adamyan was appointed CEO of Sanofi (Sanofi) in the Eurasian region.

In September 2018, the company announced the transfer of Naira Adamyan to work at Sanofi headquarters in Paris.

2021: Joining the Board of Directors of Magnit

September 13, 2021 it became known about the approval of the new composition of the board of directors of Magnit. The number of members in it increased from 9 to 11. Among the new participants, Naira Adamyan, head of strategy and innovation at the global business unit of Sanofiheadquarters, who became the first woman on the retailer's board of directors. More details here.